EGM
BHVN

Engineers Gate Manager’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Engineers Gate Manager’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,556
Closed -$538K – 2153
2022
Q3 		$538K Buy
3,556
+1,870
+111% +$277K 0.03% 762
2022
Q2 		$246K Sell
1,686
-22,403
-93% -$2.86M 0.01% 1532
2022
Q1 		$2.86M Buy
+24,089
New +$3M 0.11% 218
2021
Q4 		– Sell
-2,757
Closed -$383K – 2408
2021
Q3 		$383K Buy
+2,757
New +$344K 0.02% 1042
2021
Q2 		– Sell
-14,200
Closed -$971K – 2240
2021
Q1 		$971K Buy
14,200
+480
+3% +$38.8K 0.05% 597
2020
Q4 		$1.18M Buy
+13,720
New +$1.16M 0.05% 522

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Engineers Gate Manager's BHVN Position: Q4 2022 in Review

Engineers Gate Manager sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 3,556 shares — an estimated $538K sold.

Engineers Gate Manager first reported a position in BHVN in Q4 2020 and held it in 6 quarters. The position peaked at $2.86M in Q1 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Engineers Gate Manager reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 3,556 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $538K.
  • Engineers Gate Manager first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2020 and held it in 6 quarters.
  • Engineers Gate Manager's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $2.86M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Engineers Gate Manager's 13F filing for Q4 2022, filed 14 Feb 2023.